TWIST1 and nonpapillary renal cell carcinoma: Additionally, based on TCGA online database UALCAN (http://ualcan.path.uab.edu/), we found elevating TWIST1 levels (using 25% of samples with the highest TWIST1 expression) led to a significantly lower survival rate in ccRCC patients (Fig. 2n).